共 50 条
- [11] Anti-tumor activity and trafficking of self, tumor-specific T cells against tumors located in the brainCANCER IMMUNOLOGY IMMUNOTHERAPY, 2008, 57 (09) : 1279 - 1289Prins, Robert M.Shu, Chengyi J.Radu, Caius G.Vo, Dan D.Khan-Farooqi, HaumithSoto, HoracioYang, Meng-YinLin, Muh-ShiShelly, StephanieWitte, Owen N.Ribas, AntoniLiau, Linda M.
- [12] Combination of lentivector immunization and low-dose chemotherapy or PD-1/PD-L1 blocking primes self-reactive T cells and induces anti-tumor immunityEUROPEAN JOURNAL OF IMMUNOLOGY, 2011, 41 (08) : 2217 - 2228Sierro, Sophie R.Donda, AlenaPerret, RachelGuillaume, PhilippeYagita, HideoLevy, FredericRomero, Pedro
- [13] Interaction of PD-L1 on tumor cells with PD-1 on tumor-specific T cells as a mechanism of immune evasion: implications for tumor immunotherapyCancer Immunology, Immunotherapy, 2005, 54 : 307 - 314Christian BlankThomas F. GajewskiAndreas Mackensen
- [14] Interaction of PD-L1 on tumor cells with PD-1 on tumor-specific T cells as a mechanism of immune evasion: implications for tumor immunotherapyCANCER IMMUNOLOGY IMMUNOTHERAPY, 2005, 54 (04) : 307 - 314Blank, CGajewski, TFMackensen, A
- [15] Regulatory T Cells in Tumor-Associated Tertiary Lymphoid Structures Suppress Anti-tumor T Cell ResponsesIMMUNITY, 2015, 43 (03) : 579 - 590Joshi, Nikhil S.Akama-Garren, Elliot H.Lu, YisiLee, Da-YaeChang, Gregory P.Li, AmyDuPage, MichelTammela, TuomasKerper, Natanya R.Farago, Anna F.Robbins, RebeccaCrowley, Denise M.Bronson, Roderick T.Jacks, Tyler
- [16] PD-1 silencing improves anti-tumor activities of human mesothelin-targeted CAR T cellsHUMAN IMMUNOLOGY, 2021, 82 (02) : 130 - 138Liu, GuodiZhang, QianLi, DehuaZhang, LinsongGu, ZhangjieLiu, JibinLiu, GuopingYang, MuGu, JinweiCui, XingbingPan, YingjiaoTian, Xiaoli
- [17] Tumor sialylation impedes T cell mediated anti-tumor responses while promoting tumor associated-regulatory T cellsONCOTARGET, 2016, 7 (08) : 8771 - 8782Perdicchio, MaurizioCornelissen, Lenneke A. M.Streng-Ouwehand, IngeborgEngels, SteefVerstege, Marleen I.Boon, LouisGeerts, Dirkvan Kooyk, YvetteUnger, Wendy W. J.
- [18] Combining CD27 costimulation and PD-1 blockade into a bispecific antibody improves T cell activation and anti-tumor activity over combination of individual antibodiesJOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7Vitale, LauraThomas, LawrenceO'Neill, ThomasWidger, JeniferMills-Chen, LauraCrocker, AndreaPatterson, ColleenWasiuk, AnnaForsberg, EricBoyer, JamesSisson, CrystalWeidlick, JeffreyRenn-Bingham, ShannonPapayannopoulos, IoannisHammond, RussGoldstein, JoelMarsh, Henry, Jr.He, Li-ZhenYellin, MichaelKeler, TiborKeler, Tibor
- [19] Cbl inhibition increases the response of cytotoxic T cells to sub-optimal stimulation and drives enhanced anti-tumor responses alone or in combination with PD-1 blockadeCANCER RESEARCH, 2024, 84 (06)Yamashiro, LiviaMarubayashi, SachieRayaji, RameshwariBattsooj, AnudariMrouj, KarimSingh, HemaLee, Yue TongChen, AdaShen, LundaMailyan, ArturYu, KaiPodunavac, MashaYu, JulieLiu, DongdongHardman, ClaytonYin, JohnnyGangam, SrikanthLawson, KenLeleti, ManmohanWalters, MatthewDiRenzo, Daniel
- [20] Selective regulatory T cell depletion by anti-CCR8 antibody enhances anti-tumor immunityCANCER SCIENCE, 2025, 116 : 806 - 806Ohkura, NaganariYasumizu, YoshiakiHagiwara, MasakiKidani, YujiroFuji, HiroakiIwaisako, KeikoNakamura, YamamiSakaguchi, Shimon